AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

The median follow-up duration for the entire cohort was 10.2 years, totaling 312,882 person-years of follow-up. Of these, ...

AstraZeneca PLC AZN shares advanced 1.83% to £99.03 Friday, on what proved to be an all-around poor trading session for the ...

A Phase III trial with the companies’ monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps met its ...

Amgen (NASDAQ:AMGN) and AstraZeneca (NASDAQ:AZN) announced Friday that their FDA-approved asthma therapy Tezspire reached ...

In big pharma, AstraZeneca will talk to investors after having its head of China operations detained, a crucial market for ...

AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...

AstraZeneca is holding crisis talks with the Chinese authorities after the arrest of its boss in the country. The ...

Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and ...

AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...

Stay in the know with a recap of our top stories today. 1. AstraZeneca to open new $2b facility in Tuas by 2029, promises 800 ...

BEIJING - Pharmaceutical giant AstraZeneca said that the head of its China operations had been detained, after reports the ...